Page last updated: 2024-09-03

rasagiline and Cacosmia

rasagiline has been researched along with Cacosmia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berkovich, E; Brundin, P; Fitzer-Attas, C; Fog, K; Hickery, M; Kallunki, P; Petit, GH1
Fauser, M; Haehner, A; Hummel, T; Klingelhöfer, L; Reichmann, H; Storch, A; Wolz, M1
Habersack, A; Haehner, A; Hummel, T; Reichmann, H; Storch, A; Wienecke, M1
Alvarez, MV; Grogan, PM1

Trials

2 trial(s) available for rasagiline and Cacosmia

ArticleYear
Effects of rasagiline on olfactory function in patients with Parkinson’s disease.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:14

    Topics: Administration, Intranasal; Aged; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Olfaction Disorders; Olfactometry; Parkinson Disease; Prospective Studies; Psychophysics; Quality of Life; Severity of Illness Index

2013
Hyposmia in Parkinson's disease.
    Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:4

    Topics: Humans; Indans; Monoamine Oxidase Inhibitors; Olfaction Disorders; Parkinson Disease

2012

Other Studies

2 other study(ies) available for rasagiline and Cacosmia

ArticleYear
Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Age Factors; alpha-Synuclein; Animals; Disease Models, Animal; Humans; Indans; Memory, Short-Term; Mice; Mice, Transgenic; Monoamine Oxidase Inhibitors; Olfaction Disorders; Olfactory Bulb; Parkinson Disease; Smell

2013
Early Parkinson's disease patients on rasagiline present with better odor discrimination.
    Journal of neural transmission (Vienna, Austria : 1996), 2015, Volume: 122, Issue:11

    Topics: Antiparkinson Agents; Cross-Sectional Studies; Discrimination, Psychological; Female; Humans; Indans; Levodopa; Male; Middle Aged; Neuroprotective Agents; Odorants; Olfaction Disorders; Olfactory Perception; Parkinson Disease; Physical Stimulation; Prospective Studies; Psychophysics; Sensory Thresholds; Severity of Illness Index; Treatment Outcome

2015